Xiamen Innovax Biotech Co., Ltd.(XM-Innovax), a newly founded biotech company in Xiamen, China, is focusing on developing, manufacturing and marketing innovative vaccines and diagnostic reagents.

Our mission is providing the world community with newest diagnostic products and novel vaccines for disease prevention and controls.  We are committed to conduct research and development of human vaccines with the most advanced biotechnology and management procedures. 

In collaboration with the National Institute of Diagnostics and Vaccine Development of Xiamen University, since 1999, we have achieved unique advantage in producing vaccine based on E. coli expression platform.  At present, our hepatitis E vaccine is at planning stage for phase III clinical trial.  Another vaccine-HPV vaccine is in its late pre-clinic status.